Complete Filing Data
Abivax S.A. reported Number Of Shares Issued of 78.54 million shares for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Abivax S.A. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Sales And Marketing Expense | $5.2M | $6.0M | $6.4M | $0.00 | $0.00 |
| Revenue And Operating Income | $4.6M | $12.4M | $4.6M | $4.6M | $12.0M |
| Research And Development Expense | $177.8M | $146.5M | $103.2M | $48.3M | $47.8M |
| Profit Loss From Operating Activities | -$246.1M | -$173.0M | -$127.4M | -$64.8M | -$41.4M |
| Profit Loss Before Tax | -$330.3M | -$176.2M | -$147.7M | -$60.7M | -$42.5M |
| Profit Loss | -$336.1M | -$176.2M | -$147.7M | -$60.7M | -$42.5M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net Of Tax | $93.0K | -$31.0K | $112.0K | $235.0K | $169.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net Of Tax | $2.4M | -$187.0K | $112.0K | $0.00 | $0.00 |
| Other Comprehensive Income Net Of Tax Gains Losses On Remeasurements Of Defined Benefit Plans | $93.0K | -$31.0K | $112.0K | $235.0K | $169.0K |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | $2.4M | -$187.0K | $112.0K | $0.00 | $0.00 |
| Other Comprehensive Income | $2.5M | -$219.0K | $225.0K | $235.0K | $169.0K |
| Income Tax Expense Continuing Operations | $5.8M | $0.00 | $0.00 | $0.00 | $0.00 |
| General And Administrative Expense | $67.7M | $32.9M | $22.4M | $7.5M | $5.6M |
| Comprehensive Income | -$333.6M | -$176.5M | -$147.5M | -$60.5M | -$42.3M |
| Retained Earnings Profit Loss For Reporting Period | -$336.1M | -$176.2M | -$147.7M | -$60.7M | -$42.5M |
| Retained Earnings Excluding Profit Loss For Reporting Period | -$402.4M | -$262.6M | -$135.2M | -$82.8M | -$39.4M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $516.7M | $144.2M | $251.9M | $27.0M | $60.7M | $29.3M |
| Intangible Assets Other Than Goodwill | $6.6M | $6.6M | $6.6M | $6.6M | $93.0K | $97.0K |
| Property Plant And Equipment Including Rightofuse Assets | $2.1M | $2.7M | $878.0K | $1.6M | $305.0K | $493.0K |
| Trade And Other Current Payables | $37.6M | $43.8M | $47.2M | $15.5M | $18.6M | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $142.0K | $640.0K | $265.0K | $288.0K | $47.0K | |
| Other Noncurrent Nonfinancial Assets | $625.0K | $948.0K | $2.3M | $1.0M | $0.00 | |
| Other Noncurrent Financial Assets | $5.4M | $5.9M | $12.9M | $11.7M | $1.3M | |
| Other Inflows Outflows Of Cash Classified As Financing Activities | $300.0K | $245.0K | $163.0K | $3.0K | $0.00 | |
| Other Current Financial Assets | $21.4M | $7.6M | $9.2M | $0.00 | $0.00 | |
| Noncurrent Liabilities | $66.1M | $70.6M | $40.4M | $16.9M | $51.0M | |
| Noncurrent Derivative Financial Liabilities | $0.00 | $3.6M | $0.00 | $566.0K | $9.9M | |
| Noncurrent Assets | $33.1M | $34.6M | $41.1M | $39.4M | $33.7M | |
| Increase Decrease Through Appropriation Of Retained Earnings | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Goodwill | $18.4M | $18.4M | $18.4M | $18.4M | $32.0M | |
| Equity And Liabilities | $584.3M | $205.2M | $327.1M | $75.5M | $109.2M | |
| Current Tax And Employee Benefit Liabilities | $7.1M | $4.7M | $6.1M | $2.3M | $2.2M | |
| Current Receivables And Current Prepaid Expenses | $13.1M | $18.9M | $24.8M | $9.2M | $14.8M | |
| Current Liabilities | $63.0M | $94.0M | $90.7M | $51.5M | $32.3M | |
| Current Derivative Financial Liabilities | $0.00 | $1.2M | $2.6M | $0.00 | $0.00 | |
| Current Assets | $551.2M | $170.7M | $286.0M | $36.2M | $75.5M | |
| Cash Flows From Used In Operations Before Changes In Working Capital | -$164.8M | -$155.5M | -$118.4M | -$51.9M | -$44.4M | |
| Cash Flows From Used In Operating Activities | -$161.1M | -$154.1M | -$97.1M | -$53.9M | -$45.0M | |
| Cash Flows From Used In Investing Activities | -$8.2M | $15.8M | -$8.1M | -$12.0M | -$6.2M | |
| Cash Flows From Used In Financing Activities | $547.3M | $28.2M | $335.3M | $32.2M | $82.7M | |
| Assets | $584.3M | $205.2M | $327.1M | $75.5M | $109.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Proceeds From Issuing Shares | 648.1M | 0.00 | 353.4M | 46.2M | 69.7M |
| Proceeds From Reimbursements Of Deposits | $500.0K | $9.1M | $741.0K | $218.0K | $0.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | $911.0K | $458.0K | $529.0K | $301.0K | $249.0K |
| Increase Decrease In Working Capital | -$3.7M | -$1.4M | -$21.3M | $2.0M | $667.0K |
| Increase Decrease In Cash And Cash Equivalents | $372.5M | -$107.7M | $225.0M | -$33.8M | $31.4M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -$10.3M | $2.4M | -$5.1M | $0.00 | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Number Of Shares Issued | 78.5M | 63.3M | 62.9M | 22.3M | 16.8M | 14.3M |
| Weighted Average Shares | 69.5M | 63.0M | 43.1M | 19.1M | 15.5M | |
| Diluted Earnings Loss Per Share | $-4.83 | $-2.80 | $-3.43 | $-3.18 | $-2.75 | |
| Basic Earnings Loss Per Share | $-4.83 | $-2.80 | $-3.43 | $-3.18 | $-2.75 | |
| Adjusted Weighted Average Shares | 69.5M | 63.0M | 43.1M | 19.1M | 15.5M | |
| Increase Decrease In Number Of Ordinary Shares Issued Through Capital Increase | 11.7M | 40.3M | 5.5M | 2.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Other Income | $4.6M | $12.4M | $4.6M | $4.6M | $12.0M |
| Operating Expense | $250.6M | $185.4M | $132.0M | $69.4M | $53.4M |
| Finance Income Cost | -$84.2M | -$3.3M | -$20.4M | $4.1M | -$1.1M |
| Finance Income | $27.5M | $13.7M | $7.5M | $11.1M | $2.5M |
| Finance Costs | $111.7M | $17.0M | $27.9M | $7.0M | $3.6M |
| Repayments Of Convertible Loans Notes | $2.2M | $8.8M | $27.2M | $0.00 | $0.00 |
| Share Premium | $1.19B | $478.9M | $478.2M | $150.5M | $107.6M |
| Reserve Of Exchange Differences On Translation | $2.3M | -$75.0K | $112.0K | $0.00 | $0.00 |
| Repayments Of Conditional Advances | $0.00 | $2.7M | $110.0K | $90.0K | $70.0K |
| Other Longterm Provisions | $28.8M | $819.0K | $30.0K | $40.0K | $98.0K |
| Other Current Borrowings And Current Portion Of Other Noncurrent Borrowings | $1.3M | $22.2M | $1.7M | $10.1M | $9.6M |
| Other Adjustments For Noncash Items | $270.0K | $204.0K | $22.0K | -$100.0K | $98.0K |
| Noncurrent Provisions For Employee Benefits | $627.0K | $756.0K | $629.0K | $610.0K | $693.0K |
| Noncurrent Portion Of Other Noncurrent Borrowings | $554.0K | $29.1M | $2.6M | $9.1M | $16.5M |
| Non Current Royalty Certificates | $30.2M | $13.0M | $12.2M | $3.3M | $0.00 |
| Non Current Convertible Loans Notes | $0.00 | $23.4M | $21.6M | $0.00 | $18.2M |
| Issued Capital | $785.0K | $633.0K | $629.0K | $223.0K | $168.0K |
| Interest Received Classified As Investing Activities | $5.5M | $8.2M | $2.4M | $19.0K | $0.00 |
| Interest Paid Classified As Financing Activities | $6.5M | $7.7M | $5.3M | $4.0M | $1.9M |
| Increase Decrease Through Sharebased Payment Transactions | $35.4M | $20.2M | $8.2M | -$1.2M | $828.0K |
| Current Portion Of Non Current Convertible Loans Notes | $0.00 | $21.6M | $29.6M | $20.0M | $625.0K |
| Adjustments For Unwinding Of Discount Related To Conditional Advances | -$153.0K | -$710.0K | -$355.0K | -$2.0K | $1.9M |
| Adjustments For Sharebased Payments | $35.4M | $20.2M | $8.2M | -$1.2M | $828.0K |
| Adjustments For Other Finance Income | $23.8M | $11.6M | $3.0M | $288.0K | $0.00 |
| Adjustments For Other Finance Costs | $45.7M | $14.2M | $24.8M | $7.0M | $3.6M |
| Adjustments For Net Gain On Sale Of Treasury Shares | 0.00 | -16.0K | -34.0K | -108.0K | 0.00 |
Most recent annual filing with the SEC: March 23, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.